Market Share of Global Endometrial Cancer Industry
The endometrial cancer market is moderately competitive and consists of several major players. Due to the rising prevalence of cancer, there are several products under trial; henceforth, it is expected that a few other smaller players may enter the market. Some of the major players in the market are Bristol-Myers Squibb Company, Pfizer Inc., R-Pharm-US LLC, Elekta AB, and Siemens Healthineers (Varian Medical Systems, Inc.), among others.
Endometrial Cancer Market Leaders
Elekta AB
Karyopharm Therapeutics
Eisai Co., Ltd.
GSK plc
Siemens Healthineers (Varian Medical Systems, Inc.)
*Disclaimer: Major Players sorted in no particular order
